Skip to product information
Chewable tablet
INSTRUCTIONS:
Dogs and Cats:
Treatment or adjuvant treatment of periodontal infections caused by bacteria susceptible to amoxicillin in combination with clavulanic acid, i.e. Pasteurella spp, Streptococcus spp and Escherichia coli .
Treatment of skin infections (including wounds and abscesses) caused by bacteria susceptible to amoxicillin in combination with clavulanic acid, i.e. Pasteurella spp, Staphylococcus spp, Streptococcus spp and Escherichia coli
Cats: applies to Clavaseptin 50 mg
DOSAGE:
The recommended dose of the product is 10 mg of amoxicillin/2.5 mg of clavulanic acid per kg twice a day orally in dogs and cats, according to the following table:
In severe infections in each target species, the dose may be doubled to 20 mg amoxicillin/5 mg clavulanic acid/kg body weight twice daily. Duration of treatment: – 7 days for the treatment of periodontal infections in dogs – 7 days for the treatment of skin infections in cats (including wounds and abscesses). The animal's clinical condition should be reassessed after 7 days, and treatment will be extended for a further 7 days if necessary. In cases of severe skin infections, a longer treatment duration may be required, and this should be determined by the attending veterinarian.
CHARACTERISTICS:
-
Highly palatable.
-
Divisible tablets available in different sizes depending on the presentation.
-
Approved for use in dogs and cats.
PRESENTATION:
Box containing 10 blisters, each containing 10 tablets
ICA REGISTRATION No.
Clavaseptin 50 mg: 11043-MV
Clavaseptin 250 mg: 11042-MV
Clavaseptin 500 mg: 11058-MV
